Ayodeji Arobo

Mr. Ayodeji Arobo

Faculty of Dentistry, Obafemi Awolowo University, Ile-Ife, Osun, Nigeria
orcid
✮ Aspiring Surgeon—Scientist • Dental Student • Travel Schol...

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2026 in Community Dentistry and Oral Epidemiology
Verified
Journal Article
Closed access
PDF file
Morenike Oluwatoyin FolayanMorenike Oluwatoyin Folayan
Morenike Oluwatoyin Folayan
EOEmmanuel Oyeyemi
Emmanuel Oyeyemi
Ayodeji AroboAyodeji Arobo
Ayodeji Arobo

25 August 2026 in Discover Public Health
Verified
Journal Article
Open access
PDF file
Morenike Oluwatoyin FolayanMorenike Oluwatoyin Folayan
Morenike Oluwatoyin Folayan
MBMuhydeen Damilola Badru
Muhydeen Damilola Badru
Ayodeji AroboAyodeji Arobo
Ayodeji Arobo
BHBridget Gabrielle Haire
Bridget Gabrielle Haire
Indigenous peoples experience disproportionately high rates of HIV, highlighting a gap in access to biomedical prevention tools like Pre-Exposure Prophylax

25 March 2026 in Pediatric Anesthesia
Verified
Journal Article
Closed access
JFJohannes Fischer
Johannes Fischer
Ayodeji AroboAyodeji Arobo
Ayodeji Arobo
AAAbdullah Almehandi
Abdullah Almehandi
ELErnesto Caron Leidens
Ernesto Caron Leidens
EAEster Beatrice Apostu
Ester Beatrice Apostu
TCTulio Caldonazo
Tulio Caldonazo
1

28 May 2026 in Pediatric Transplantation
Verified
Journal Article
Open access
JFJohannes Fischer
Johannes Fischer
SSSilas Schwegmann
Silas Schwegmann
RPRichard Plem
Richard Plem
Ayodeji AroboAyodeji Arobo
Ayodeji Arobo
AAAbdullah Almehandi
Abdullah Almehandi
TCTulio Caldonazo
Tulio Caldonazo
Objectives: Heart transplantation is the gold standard therapy for pediatric end‐stage heart failure. Ventricular assist devices (VADs) have improved waitlist survival, but their effect on post‐transplant outcomes remains uncertain. This study aimed to evaluate the impact of pre‐transplant VAD support on outcomes in pediatric heart transplant recipients. Methods: We performed a systematic review and a meta‐analysis using three different databases to compare outcomes in pediatric heart transplant recipients with and without pre‐transplant VAD support. The primary outcome was long‐term survival. Secondary outcomes were postoperative stroke, hospital length of stay (LOS), and post‐transplantation rejection. Results: A total of 3247 studies were identified, of which five were included in the analysis. There was no significant difference in long‐term survival among patients who survived to transplantation between the groups (HR 0.963; 95% CI 0.84 to 1.10; p = 0.582). However, the postoperative stroke rate was significantly higher in the VAD group (OR 2.17; 95% CI 1.63 to 2.89; p < 0.0001), while no significant differences were observed in hospital LOS (SMD −0.09; 95% CI −0.33 to 0.14; p = 0.4375) or post‐transplant rejection (OR 1.18; 95% CI 1.00 to 1.39; p = 0.0505). Conclusions: Pre‐transplant VAD support was associated with non‐inferior survival despite greater baseline severity among patients who survived to transplantation, enabling access to transplantation, but at the cost of higher VAD‐related complications, particularly stroke, with no differences in hospital LOS or rejection.

1 May 2026 in Gastrointestinal Endoscopy
Verified
Journal Article
Closed access
IEIsmail Elkhattib
Ismail Elkhattib
AEAbdelrahman Elgendy
Abdelrahman Elgendy
MEMostafa Elkholy
Mostafa Elkholy
ASAhmad O. Saleh
Ahmad O. Saleh
Ayodeji AroboAyodeji Arobo
Ayodeji Arobo
MEMohamed Elnaggar
Mohamed Elnaggar

16 July 2026 in Community Dentistry and Oral Epidemiology
Verified
Journal Article
Closed access
PDF file
MFMoréniké Oluwátóyìn Foláyan
Moréniké Oluwátóyìn Foláyan
Ayodeji AroboAyodeji Arobo
Ayodeji Arobo
EOEmmanuel Oyeyemi
Emmanuel Oyeyemi
ABAhmed Bhayat
Ahmed Bhayat
MTMaha El Tantawi
Maha El Tantawi